Skip to product information
Tirzepatide — Powder

Tirzepatide — Powder

$169.95

Third-Party Tested · Verified Purity · Fast U.S. Shipping

✦ Earn 0 Helixera Points with this purchase
Strength
HELIXERA LABS
Batch Analytics
Independent Analytical Verification
Purity
99.852%
Method
RP-HPLC
Batch
C126-9566-TOY-2
Status
PASS ✓
✓ Third-Party Tested ✓ Batch Specific ✓ Quality Assured

Analytical results may vary slightly between selected vial strengths and production batches. Corresponding batch documentation is available for current inventory.

Tirzepatide — Powder COA Report

Tirzepatide — Research Peptide | CAS 2023788-19-2

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. As a 39-amino acid synthetic peptide, it represents a novel class of incretin-based compounds that have generated significant interest in metabolic and endocrine research.

Preclinical and published clinical research has examined tirzepatide's effects on pancreatic beta cell function, insulin sensitivity, energy expenditure, and adipose tissue metabolism. It is among the most actively studied peptides in the current obesity and metabolic syndrome research literature, distinguished by its dual-agonist mechanism compared to GLP-1 selective compounds.

Supplied as a lyophilized powder with ≥98% purity, HPLC-verified. Certificate of Analysis available. For research use only. Not for human consumption.

You may also like